We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Is Arthritis Supplement Safe from Mad Cow Disease?

By HospiMedica staff writers
Posted on 24 Apr 2001
A rheumatology expert, Dr. More...
Gerald Weissmann, questions whether the widely marketed dietary supplement chondroitin sulfate, derived from cow cartilage, is safe from contamination with bovine spongiform encephalopathy (BSE), or mad cow disease. His investigation is chronicled on the e-magazine RheumatologyWeb.

Because both chondroitin and glucosamine are components of normal cartilage that work in the body to stimulate and maintain cartilage growth, it is thought by many people that the animal-derived supplement may be able to help the body repair cartilage damaged by arthritis. However, to date there has been no definitive evidence that glucosamine and chondroitin sulfates, either in combination or alone, can help rebuild cartilage or prevent damage to cartilage, and the American College of Rheumatology currently does not recommend their use.

A large-scale, multicenter study to investigate their use is being conducted by the U.S. National Center for Complementary and Alternative Medicine, in collaboration with the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The chondroitin being used in the study comes from a Spanish company, which claims to use only material from U.S. cows.

In the meantime, U.S. individuals taking the supplements must consider the fact that they are unregulated by the U.S. Food and Drug Administration (FDA). According to Dr. Weissmann, in order for the supplement to be considered safe from BSE, it must be derived solely from the cartilage of U.S. cows.

"With many of these supplements being manufactured in Europe, the specter is certainly raised that this may not be the case. The use of other tissues or cartilage from European cows significantly increases the risk of BSE contamination,” he explained. This means that European users or people using supplements produced in Europe must depend on supplement manufacturers to identify the origin of the cartilage used.


Related Links:
RheumatologyWeb

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.